
Endocrinologist

No OPD information available
Insulinoma
Metastatic Insulinoma
Neuroendocrine Tumor
Prostate Cancer
Adrenal Cancer
Astrocytoma
Congenital Hyperinsulinism
Embryonal Tumor with Multilayered Rosettes
Glioblastoma
Glioma
Gliomatosis Cerebri
Heart Tumor
Hyperthyroidism
Low Blood Sugar
Lung Cancer
Lymphangitis
Pancreatic Cancer
Pancreatic Islet Cell Tumor
Pheochromocytoma
Renal Cell Carcinoma (RCC)
Sarcoidosis
Thyroid Cancer
Thyroid Nodule
Ventricular Fibrillation
David A. Pattison is a male doctor who helps people with different health problems like Insulinoma, Prostate Cancer, and Lung Cancer. He also treats conditions like Low Blood Sugar and Thyroid Cancer. He is very skilled at what he does and uses special treatments to help his patients feel better.
Dr. Pattison talks to his patients in a friendly way and makes sure they understand everything about their health. Patients trust him because he listens to them and cares about their well-being. He always explains things in a simple and clear manner so that they feel comfortable and safe.
To stay updated with the latest medical knowledge, Dr. Pattison reads a lot of research papers and attends conferences. This helps him learn new things and provide the best care for his patients. He also works closely with other doctors and healthcare professionals to share ideas and improve patient outcomes.
Dr. Pattison's work has had a positive impact on many patients' lives. For example, his research on prostate cancer and a specific treatment combination has shown promising results in improving survival and quality of life. He is also involved in clinical trials to find better ways to treat cancer, like a study on a new therapy for Merkel Cell Carcinoma.
Overall, Dr. Pattison is a dedicated and caring doctor who is committed to helping his patients live healthier lives. His expertise, communication skills, and involvement in research make him a trusted and respected healthcare provider in his field.
Enrollment Status: Recruiting
Published: February 14, 2025
Intervention Type: Radiation, Drug
Study Drug: Avelumab
Study Phase: Phase 1/Phase 2
